As the meme coin rivalry heats up once again, a new twist emerges in the ongoing battle between Shiba Inu (SHIB) and Dogecoin (DOGE). While the two coins of the meme token market continue to dominate headlines, a surprising coin, Mutuum Finance (MUTM) is capturing growing investor attention. Mutuum Finance has a presale price of […]As the meme coin rivalry heats up once again, a new twist emerges in the ongoing battle between Shiba Inu (SHIB) and Dogecoin (DOGE). While the two coins of the meme token market continue to dominate headlines, a surprising coin, Mutuum Finance (MUTM) is capturing growing investor attention. Mutuum Finance has a presale price of […]

Can Shiba Inu (SHIB) Flip Dogecoin (DOGE)? This $0.035 May Have a Better Chance

As the meme coin rivalry heats up once again, a new twist emerges in the ongoing battle between Shiba Inu (SHIB) and Dogecoin (DOGE). While the two coins of the meme token market continue to dominate headlines, a surprising coin, Mutuum Finance (MUTM) is capturing growing investor attention. Mutuum Finance has a presale price of $0.035 in phase 6. Early investors will experience over 500% growth after listing. The Mutuum Finance presale has already reached over $15.25 million with over 15850 owners. Mutuum Finance could disrupt the market hierarchy and challenge dominance of Shiba Inu and Dogecoin.

Dogecoin and Shiba Inu Hold Steady Amid Meme Coin Uncertainty

Dogecoin (DOGE) is currently priced at $0.2205, while Shiba Inu (SHIB) trades at $0.00001254. Both tokens are showing limited movement as market sentiment remains cautious, with Dogecoin holding a tight range and Shiba Inu maintaining its key support level. While Shiba Inu is expected to skyrocket, its potential to flip Dogecoin (DOGE) remains low. Investors continue to watch these two meme coins closely as interest also grows in emerging decentralized finance projects such as Mutuum Finance.

Mutuum Finance Launches $50,000 Bug Bounty

MUTM has announced its Bug Bounty Program launched in collaboration with Certik. Through an invitation to white hackers, developers, and security researchers to participate in the security program, Mutuum Finance will further enhance the security of its platform by rewarding them with bounties when they identify any vulnerability they are able to discover.

The reward system will be up to 50,000 USDT and the award will also be proportional to the impact of the bug discovered whether small level bugs to high-impact bug vulnerability. The hierarchical model provides one of the widest security coverings and in the simplified form can safeguard the users, investors’ funds and profits, and gains increasing trust in the Mutuum Finance system.

$100,000 Community Giveaway to Reward Supporters

In addition to its bug bounty, Mutuum Finance team is also hosting a $100,000 giveaway that will be rewarding early project adopters and internally growing its user base. It will be rewarding 10 winners with $10,000 each. This will truly mirror the solid long term committed focus user base which the project is attempting to reach.

These community programs are one of the goals of Mutuum Finance to not only be laboring towards creating a safe environment in the form of a platform that it is creating but also be a life-nurturing organization which assists in creating a feeding environment where the users, token holders and investors will be able to reap the success.

Phase 6 Presale Achieves Major Milestones

Mutuum Finance is already a rapidly growing behemoth in the DeFi market and has achieved that by onboarding over 15,850 investors as well as having recorded a presale of over $15.25 million.

The project is currently at Stage 6 of Presale selling tokens at $0.035 per MUTM. The stage offers early birds a huge profit window where they are presented with a chance to buy in prior to the token breaking higher in subsequent stages.

Mutuum Finance (MUTM) is now in Stage 6 of its presale at $0.035, with over 15,850 holders and $15.25 million already secured. The project’s dual lending model, security-driven ecosystem, and early investor incentives position it as a serious coin to outpace not only meme tokens like SHIB and DOGE but also emerging DeFi competitors. As the next price lift approaches, the current stage offers one of the last accessible entries before momentum accelerates further.

For more information about Mutuum Finance (MUTM) visit the links below:

Website: https://mutuum.com/

Linktree: https://linktr.ee/mutuumfinance

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26